Portage Biotech soars on potential deal with Immunova
17/12/2024 13:58
** Shares of drug developer Portage Biotech Inc PRTG.O
rise 187% at $9.09 premarket
** PRTG says that it has signed a letter of intent with
Immunova for an option agreement to acquire its wholly owned
subsidiary, iOx Therapeutics
** iOx Therapeutics focuses on developing immunotherapies -
PRTG
** As of last close, stock has fallen ~91% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data